Stocks · Korea 000220 KOSPI

Yuyu Pharma

3,840원 +1.45% Market cap 605억 2026-10-07 close
Data as of 2026-10-07 · Linked from 8 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER7.80x
PBR0.54x
EPS492 KRW
BPS7,069 KRW
ROE6.64%
DPS115 KRW

Returns and 52-week range

1W+3.78%
1M+0.92%
3M+0.92%
6M-8.79%
1Y-12.23%
YTD-16.34%
52W high5,100원
52W low3,320원
From 52W high-24.71%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20221,389억-6억-44억-0.4%
20231,372억4억-55억0.3%
20241,331억117억103억8.8%
20251,409억110억91억7.8%
Quarterly
2024 4Q330억-3억-6억-0.8%
2025 1Q329억39억30억11.9%
2025 2Q358억22억6억6.3%
2025 3Q378억50억43억13.2%
2025 4Q343억-1억12억-0.4%
2026 1Q355억43억34억12.1%

Company

CEO유원상, 박노용(각자대표)
Founded1941-02-28
Fiscal year end12
Address: 충청북도 제천시 바이오밸리1로 94

Peers in the same sector

CompanyMarket capP/EP/B1M
HLB파나진621억—0.86+21.79%
쿼드메디슨580억—1.86+2.86%
팬젠640억30.752.13-4.73%
테고사이언스576억—1.13-5.96%
옵티팜657억—2.59-6.96%
진양제약568억2.200.35+0.00%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.